Recherche
-
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health
(Psychoneuroendocrinology. vol. 91, pp. 55-61, 2018-05)Article de revue -
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
(Psychoneuroendocrinology. vol. 112, pp. 104520, 2020)Article de revue -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome
(BMC Cardiovascular Disorders. vol. 15, pp. 23, 2015-03-18)Article de revueLibre accès -
Obesity and depression: shared pathophysiology and translational implications
(Academic Press, 2019)Chapitre d'ouvrage -
History of depression is associated with neuropsychiatric symptoms and augmented inflammatory markers in a cross sectional study on obese patients
(European Neuropsychopharmacology. vol. 27, pp. S627-S628, 2017)Article de revue -
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
(International Journal of Neuropsychopharmacology. vol. 25, n° 6, pp. 468-478, 2022-02-17)Article de revueLibre accès -
Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder
(Depression and Anxiety. vol. 39, n° 5, pp. 407-418, 2022-03-31)Article de revue -
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary study
(International Journal of Obesity. vol. 46, n° 4, pp. 885-888, 2022-01-10)Article de revue -
Immunoinflammation in psychiatric diseases: what leads?
(Revue du Praticien (La). vol. 67, n° 9, pp. 950-952, 2017)Article de revue -
From gut to brain: Microbiota depletion in mice as a tool to explore causality
(Brain, Behavior, and Immunity. vol. 94, pp. 4-5, 2021-05-01)Article de revue